# KPMG MSD Vietnam Pharma Strategy Project - Scope & Objectives

## Primary Objective

Develop an outside-in market growth navigation proposal for MSD HH Vietnam Ltd — identifying strategic opportunities in Vietnam's pharmaceutical ecosystem through comprehensive analysis of market fundamentals, competitive dynamics, and future scenarios.

## Key Questions to Answer

**Macro-Level Questions**:
1. What are the growth trajectories of Vietnam's pharma market (2025–2030)?
2. Which macro-economic and regulatory factors drive or hinder expansion?
3. How does Vietnam's pharma market compare to regional peers (Thailand, Indonesia, Philippines)?

**Micro-Level Questions**:
4. Where do specific opportunities exist for MSD across therapy areas and market segments?
5. What are the competitive positioning dynamics for MSD vs. MNC peers and domestic leaders?
6. What partnerships or distribution strategies could accelerate MSD's growth?

**Forward-Looking Questions**:
7. What scenarios could emerge at critical inflection points (regulatory reforms, SHI expansion, healthcare digitalization)?
8. How would MSD's market opportunity change under each scenario?
9. What inflection points should MSD actively monitor or influence?

## Success Criteria

**Market Sizing & Growth Forecasts**:
- Supported by data triangulation and CAGR benchmarks
- Clear segmentation by therapy area, channel, and customer type
- 5-year outlook with confidence intervals

**Competitive Positioning**:
- Assessment of MSD vs. MNC peers and domestic leaders
- Identification of competitive advantages and gaps
- Market share trends and implications

**Scenario Frameworks (3–4 Scenarios)**:
- With risk, opportunity, and action implications
- Clear inflection point triggers
- Probability assessment and timeline
- Specific implications for MSD's strategy

**Recommendations**:
- Concrete, actionable growth roadmap
- Measurable KPIs and success metrics
- Resource requirements and investment priorities
- Timeline and phasing for execution

## Iteration Structure

**Iteration 1 - Macro Analysis Phase**:
- Focus: Vietnam pharma market fundamentals, size, growth drivers
- Deliverable: Market overview, growth trajectories, macro factors

**Iteration 2 - Micro Opportunities Phase**:
- Focus: Market opportunities specific to MSD, competitive positioning
- Deliverable: Opportunity assessment, competitive analysis, segment prioritization

**Iteration 3 - Scenario Planning Phase**:
- Focus: Inflection point scenarios and strategic implications
- Deliverable: 3-4 scenario frameworks with risk/opportunity/action implications

## Project Context

**Client**: MSD HH Vietnam Ltd

**Team**: KPMG Deals & Strategy

**Timeline**: Execute across 3 planning iterations with approval gates

**Stakeholder Requirements**:
- Actionable insights for Vietnam market expansion
- Data-driven recommendations
- Clear risk and opportunity assessment
- Strategic flexibility across multiple scenarios
